A Immunogenicity and Safety Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 40 Years and Older

NCT07311148 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

840

Enrollment

INDUSTRY

Sponsor class

Conditions

Herpes Zoster (HZ)
Shingles
VZV
Recombinant Zoster Vaccine

Interventions

BIOLOGICAL: Low dose antigen and low dose adjuvant of LYB004
BIOLOGICAL: Low dose antigen and high dose adjuvant of LYB004
BIOLOGICAL: High dose antigen and low dose adjuvant of LYB004
BIOLOGICAL: High dose antigen and high dose adjuvant of LYB004
BIOLOGICAL: Placebo
BIOLOGICAL: Positive control

Sponsor

Guangzhou Patronus Biotech Co., Ltd.